1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sinopharm Group Co. Ltd.
  6. News
  7. Summary
    1099   CNE100000FN7

SINOPHARM GROUP CO. LTD.

(1099)
  Report
Delayed Hong Kong Stock Exchange  -  03:11 2022-08-17 am EDT
16.94 HKD   -2.64%
08/09SY Holdings Bags $6 Million Contract to Supply Sinopharm-Affiliated Hospitals with Software Systems
MT
07/08Sinopharm Mulls $1 Billion Purchase of DNA Products Supplier BBI Life Sciences
MT
06/27SINOPHARM GROUP CO. LTD. : Ex-dividend day for final dividend
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about SINOPHARM GROUP CO. LTD.
06/27SINOPHARM GROUP CO. LTD. : Ex-dividend day for final dividend
FA
06/23Sinopharm Group Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2021, ..
CI
06/17Sinopharm Group Co. Ltd. Announces Executive Changes
CI
06/10Sinopharm Group Co. Ltd. Announces Resignation of Deng Jindong as Member of Audit Commi..
CI
06/02Sinopharm Group Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2021, ..
CI
04/22Sinopharm Group's Attributable Profit Rises in Q1
MT
04/19Sinopharm Group Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31,..
CI
04/19Sinopharm Group Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31,..
CI
04/15Sinopharm's New Drug Found Effective Against Delta, Omicron COVID-19 Strains
MT
03/31Sinopharm Group Co. Ltd. Enters into Strategic Commercial Cooperation with TSB Therapeu..
CI
03/25UBS Adjusts Sinopharm's Price Target to HK$28 From HK$30, Keeps at Buy
MT
03/20Sinopharm Group Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2021, ..
CI
03/20Sinopharm Group Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, ..
CI
03/18Sinopharm Arm's Profit Falls in 2021
MT
01/04WHO sees more evidence that Omicron causes milder symptoms
RE
More most relevant news
All news about SINOPHARM GROUP CO. LTD.
08/09SY Holdings Bags $6 Million Contract to Supply Sinopharm-Affiliated Hospitals with Soft..
MT
07/08Sinopharm Mulls $1 Billion Purchase of DNA Products Supplier BBI Life Sciences
MT
06/27SINOPHARM GROUP CO. LTD. : Ex-dividend day for final dividend
FA
06/23Sinopharm Group Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2021, ..
CI
06/21Some Omicron sub-variants escaping antibodies from Sinopharm shot -Chinese study
RE
06/17Sinopharm Group Co. Ltd. Announces Executive Changes
CI
06/10Sinopharm Group Co. Ltd. Announces Resignation of Deng Jindong as Member of Audit Commi..
CI
06/10ChromaDex Signs Tru Niagen Distribution Deal With Sinopharm Xingsha; Shares Climb Prema..
MT
06/02Sinopharm Group Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2021, ..
CI
05/19CanSino Biologics Rises After WHO Approves Covid Vaccine for Emergency Use
DJ
More news
News in other languages on SINOPHARM GROUP CO. LTD.
08/05Carl Zeiss Meditec profitiert von nachgeholten Augenbehandlungen
07/23China dice que las vacunas COVID son seguras y revela que sus líderes las han recibido
07/08Sinopharm envisage d'acheter pour 1 milliard de dollars le fournisseur de produits ADN ..
06/23Sinopharm Group Co., Ltd. approuve le dividende final pour l'année se terminant le 31 d..
06/17Sinopharm Group Co. Ltd. annonce des changements au niveau de la direction
06/10Sinopharm Group Co. Ltd. annonce la démission de Deng Jindong en tant que membre du com..
06/10ChromaDex signe un accord de distribution de Tru Niagen avec Sinopharm Xingsha ; les ac..
06/02Sinopharm Group Co., Ltd. Propose un dividende final pour l'année se terminant le 31 dé..
05/23CORONA-BLOG/ASTRAZENECA : Vaxzevria nun in der EU als Booster zugelassen
05/19ChromaDex forme une coentreprise pour vendre le supplément Tru Niagen en Chine ; les ac..
More news
Analyst Recommendations on SINOPHARM GROUP CO. LTD.
03/25UBS Adjusts Sinopharm's Price Target to HK$28 From HK$30, Keeps at Buy
MT
More recommendations
Press releases
2021SINOPHARM : 2021 Interim Report
PU
2021SINOPHARM : Form of proxy for domestic shareholders' class meeting
PU
2021SINOPHARM : Form of proxy for h shareholders' class meeting
PU
2021SINOPHARM : Form of proxy for annual general meeting
PU
2021SINOPHARM : Notice of the domestic shareholders' class meeting
PU
More press releases
Upcoming event on SINOPHARM GROUP CO. LTD.